Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Optimization in Treatment-Resistant Depression
NCT01945047Phase 3Completed
- Sponsor
- University of Ottawa
- Start
- May 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in treatment-resistant depression (TRD), sponsored by University of Ottawa. Started May 2013; status: completed.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT01945047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945047.